Welcome to our dedicated page for Rentokil Initial Plc SEC filings (Ticker: RTO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking pest-control acquisitions, cross-border revenue splits, or executive stock sales in Rentokil Initial’s SEC docket can feel like chasing insects in the dark. The London-based leader’s route-based pest and hygiene model spans 80+ countries, so each Form 6-K, 20-F, or swift 8-K arrives packed with segment data, currency translations, and risk factors. If you have ever searched “Rentokil Initial SEC filings explained simply” or wondered about “Rentokil Initial insider trading Form 4 transactions” before the market reacts, this page lights the way.
Stock Titan’s AI reads every submission the instant it lands on EDGAR and translates dense text into plain-English briefs. Whether you type “Rentokil Initial quarterly earnings report 10-Q filing” (mapped to the nearest 6-K), “Rentokil Initial annual report 10-K simplified” (our link to the Form 20-F), or “Rentokil Initial proxy statement executive compensation”, the platform pinpoints the numbers that matter—like hygiene-segment margins or integration costs from the Terminix deal. Real-time alerts surface “Rentokil Initial Form 4 insider transactions real-time” so you never miss developing trends.
- Form 20-F / 10-K equivalent: global revenue splits, pest-control margins, major risks
- 6-K / 10-Q style updates: quarterly hygiene performance and cash generation
- Form 4: Rentokil Initial executive stock transactions Form 4 with instant AI context
- 8-K: “Rentokil Initial 8-K material events explained” for acquisitions and leadership changes
Use the dashboard for “Rentokil Initial earnings report filing analysis,” compare route-based growth, or download data tables. By “understanding Rentokil Initial SEC documents with AI,” you focus on decisions, not document hunting.
Janus Henderson Group plc reports beneficial ownership of common stock in Rentokil Initial plc totaling 142,879,790 shares, representing approximately 5.7% of the class. The filing identifies the reporting person as an investment adviser (Type IA, HC) and discloses that certain indirect subsidiaries (including JHIUS) may be deemed beneficial owners of a portion of the position, with JHIUS shown as beneficially owning 127,751,451 shares (about 5.1% of the class).
The filing states these securities were acquired and are held in the ordinary course of business and were not acquired to change or influence control of the issuer. A power of attorney authorizes named company employees to execute filings on Janus Henderson's behalf.
H1 2025 highlights: Revenue from continuing operations grew 3.1 % YoY to $3.36 bn (1.6 % organic). Adjusted operating profit slipped 4.5 % to $511 m, cutting margin 120 bps to 15.2 %. Adjusted PBT was $418 m (-7.8 %) and adjusted EPS 12.46 c (-11 %). Statutory PBT fell 26 % to $216 m after a $79 m increase in the termite-damage provision.
Cash & capital: Free cash flow rose 31 % to $282 m with 93 % conversion (vs 80 % guidance). Net debt climbed to $4.22 bn, or 2.8× adjusted EBITDA, largely due to bond financing and FX; liquidity headroom is $2.0 bn. Interim dividend maintained at 4.15 c.
Operating trends: North America revenue +2.0 % (organic +1.1 %) but adjusted profit -7.3 % and margin 16.9 %. International revenue +5.1 %, adjusted profit +4.6 %, margin steady at 19.3 %. Group organic growth improved in Q2, with North America organic growth 1.4 % versus 0.7 % in Q1. Integration of Terminix continues; ~$100 m cost-reduction target and >20 % NA margin post-2026 reiterated. FY-25 outlook and technical guidance unchanged.
On 24 Jul 2025 sovereign wealth fund GIC Private Limited crossed a disclosure threshold in Rentokil Initial plc, triggering this Form 6-K/TR-1 major-holdings notice. GIC now controls 6.494659 % of Rentokil’s voting rights, equal to 164.06 million votes. The stake consists of 5.940639 % (150.06 m votes) held via ordinary shares and 0.554020 % (13.99 m votes) linked to security-lending arrangements.
The change is primarily a reclassification of part of the holding as “security lending” rather than a meaningful purchase or sale; the previously reported total was 6.500133 %. No financial results, guidance or operational updates are included. The filing, dated 28 Jul 2025, fulfils UK Disclosure & Transparency Rule 5 obligations and has limited direct impact on Rentokil’s fundamentals.